PDLI

PDL BioPharma, Inc.
PDLI

Overview Fund Activity
Delisted

PDLI was delisted on the 30th of December, 2020.

Back to rankings

140 hedge funds and large institutions have $214M invested in PDL BioPharma, Inc. in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 37 increasing their positions, 59 reducing their positions, and 22 closing their positions.

Holders
140
Holders Change
-8
Holders Change %
-5.41%
% of All Funds
3.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
37
Reduced
59
Closed
22
Calls
$191K
Puts
$47K
Net Calls
+$144K
Net Calls Change
-$174K

Top Buyers

1
BIP
1
Brandes Investment Partners
California
$11.8M
2
Morgan Stanley
2
Morgan Stanley
New York
$3.5M
3
CM
3
Crestline Management
Texas
$1.89M
4
State of New Jersey Common Pension Fund D
4
State of New Jersey Common Pension Fund D
New Jersey
$1.59M
5
JPMorgan Chase & Co
5
JPMorgan Chase & Co
New York
$1.65M

Top Sellers

1
State Street
1
State Street
Massachusetts
$7.34M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$13.5M
3
Arrowstreet Capital
3
Arrowstreet Capital
Massachusetts
$862K
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$22.1M
5
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$5.46M
Name Market Value Shares Shares
Change 		Shares
Change %
BlackRock
1
BlackRock
New York
$23.9M 11,085,728 +31,238 +0.3%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$22.1M 10,212,232 -835,029 -8%
Renaissance Technologies
3
Renaissance Technologies
New York
$20.2M 9,364,285 +343,203 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$13.5M 6,241,144 -3,085,747 -33%
BIP
5
Brandes Investment Partners
California
$11.8M 5,465,156 +1,293,185 +31%
Northern Trust
6
Northern Trust
Illinois
$9.68M 4,480,573 -154,632 -3%
Connor, Clark & Lunn Investment Management (CC&L)
7
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$9.48M 4,387,038 -100,546 -2%
Charles Schwab
8
Charles Schwab
California
$7.93M 3,672,122 -2,019 -0.1%
State Street
9
State Street
Massachusetts
$7.34M 3,398,172 -3,421,999 -50%
Citadel Advisors
10
Citadel Advisors
Florida
$6.48M 3,000,284 -7,268 -0.2%
Royal Bank of Canada
11
Royal Bank of Canada
Ontario, Canada
$5.46M 2,528,693 -635,380 -20%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4.66M 2,156,167 +205,719 +11%
AQR Capital Management
13
AQR Capital Management
Connecticut
$3.75M 1,737,877 -1,836 -0.1%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$3.72M 1,722,199 -224,293 -12%
Morgan Stanley
15
Morgan Stanley
New York
$3.5M 1,620,501 +1,198,656 +284%
WG
16
Winton Group
United Kingdom
$3.4M 1,573,780 +186,895 +13%
UBS Group
17
UBS Group
Switzerland
$2.9M 1,343,993 +394,537 +42%
Grantham, Mayo, Van Otterloo & Co (GMO)
18
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$2.87M 1,329,600 -349,300 -21%
Fuller & Thaler Asset Management
19
Fuller & Thaler Asset Management
California
$2.39M 1,105,970 -137,155 -11%
BCM
20
Bridgeway Capital Management
Texas
$2.1M 971,800 – –
Goldman Sachs
21
Goldman Sachs
New York
$2.09M 968,999 +466,202 +93%
Invesco
22
Invesco
Georgia
$2.08M 962,532 -2,915 -0.3%
Russell Investments Group
23
Russell Investments Group
United Kingdom
$2.02M 932,384 +498,528 +115%
CM
24
Crestline Management
Texas
$1.89M 875,000 +725,000 +483%
Nomura Holdings
25
Nomura Holdings
Japan
$1.76M 823,305 -152,706 -16%
1
2 3 4 5